An Exploratory Study for AD-810N in Patients with Parkinsonism in Dementia with Lewy Bodies (Phase 2 study)
Phase 2
- Conditions
- Parkinsonism in Dementia with Lewy Bodies
- Registration Number
- JPRN-jRCT2080221994
- Lead Sponsor
- Dainippon Sumitomo Pharma Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Patients met the diagnostic criteria of probable DLB
-Outpatients
-Patients taking L-DOPADCI in succession more than 12 weeks
etc.
Exclusion Criteria
-Patients with parkinsonism excepting Dementia with Lewy Bodies
-Patients with Parkinson's disease with dementia
-Epileptic patients
-Patients treated with zonisamide
etc.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method